Travere Therapeutics, Inc.
TVTX
50 insider filings · Latest: Jun 22, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2026 | Apr 14 8:02 PM | SANDRA CALVIN | Proposed Sale | 21,977 | $41.07 | $902.6K | — | View → |
| Apr 13, 2026 | Apr 14 12:11 AM | Christopher Cline | Proposed Sale | 65 | $28.85 | $1.9K | — | View → |
| Apr 6, 2026 | Apr 7 10:17 PM | Roy D. BaynesDirector | Sale | 10,000 | $33.00 | $330.0K | 37,500(D) | View → |
| Apr 6, 2026 | Apr 6 8:06 PM | ROY BAYNES | Proposed Sale | 10,000 | $33.00 | $330.0K | — | View → |
| Apr 1, 2026 | Apr 2 9:55 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 60,000 | $30.93 | $1.9M | 432,886(D) | View → |
| Apr 1, 2026 | Apr 2 9:55 PM | Elizabeth E ReedChief Legal Officer and GC | Sale | 10,000 | $30.00 | $300.0K | 105,211(D) | View → |
| Apr 1, 2026 | Apr 1 8:13 PM | Dube Eric M | Proposed Sale | 60,000 | $30.93 | $1.9M | — | View → |
| Apr 1, 2026 | Apr 1 8:06 PM | ELIZABETH REED | Proposed Sale | 10,000 | $30.00 | $300.0K | — | View → |
| Mar 16, 2026 | Mar 18 8:05 PM | Elizabeth E ReedChief Legal Officer and GC | Sale | 10,000 | $28.09 | $280.9K | 105,211(D) | View → |
| Mar 16, 2026 | Mar 16 8:20 PM | ELIZABETH REED | Proposed Sale | 10,000 | $28.09 | $280.9K | — | View → |
| Feb 20, 2026 | Feb 24 9:05 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 60,000 | $30.10 | $1.8M | 432,886(D) | View → |
| Feb 20, 2026 | Feb 20 9:49 PM | Dube Eric M | Proposed Sale | 60,000 | $30.10 | $1.8M | — | View → |
| Feb 17, 2026 | Feb 19 9:10 PM | Elizabeth E ReedChief Legal Officer and GC | Sale | 10,000 | $27.83 | $278.3K | 105,211(D) | View → |
| Feb 17, 2026 | Feb 17 9:30 PM | ELIZABETH REED | Proposed Sale | 10,000 | $27.83 | $278.3K | — | View → |
| Feb 4, 2026 | Feb 5 9:05 PM | Jula InrigCHIEF MEDICAL OFFICER | Sale | 1,779 | $32.21 | $57.3K | 105,706(D) | View → |
| Feb 4, 2026 | Feb 5 9:05 PM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Sale | 1,745 | $32.19 | $56.2K | 111,226(D) | View → |
| Feb 4, 2026 | Feb 5 9:05 PM | Elizabeth E ReedChief Legal Officer and GC | Sale | 2,994 | $32.18 | $96.4K | 105,211(D) | View → |
| Feb 4, 2026 | Feb 4 9:07 PM | ELIZABETH REED | Proposed Sale | 2,994 | $32.18 | $96.4K | — | View → |
| Feb 4, 2026 | Feb 4 9:06 PM | JULA INRIG | Proposed Sale | 1,779 | $32.21 | $57.3K | — | View → |
| Feb 4, 2026 | Feb 4 9:01 PM | CHRISTOPHER CLINE | Proposed Sale | 1,745 | $32.19 | $56.2K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jan 31, 2026 | Feb 4 2:30 AM | William E. RoteChief Research Officer | Grant/Award | 53,570 | $33.10 | 53,570(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Grant/Award | 20,160 | $33.10 | 20,160(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Elizabeth E ReedChief Legal Officer and GC | Grant/Award | 66,960 | $33.10 | 66,960(D) | View → |
| Jan 27, 2026 | Jan 28 1:25 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 51,865 | $15.46 | 120,000(D) | View → |
| Jan 23, 2026 | Jan 28 1:25 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 8,135 | $15.46 | 171,865(D) | View → |
| Jan 20, 2026 | Jan 21 9:05 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $19.08 | 30,000(D) | View → |
← Previous
Page 3 of 3